3ttz: Difference between revisions
From Proteopedia
Jump to navigationJump to search
m Protected "3ttz" [edit=sysop:move=sysop] |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3ttz.jpg|left|200px]] | |||
The | <!-- | ||
The line below this paragraph, containing "STRUCTURE_3ttz", creates the "Structure Box" on the page. | |||
You may change the PDB parameter (which sets the PDB file loaded into the applet) | |||
or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |||
or leave the SCENE parameter empty for the default display. | |||
--> | |||
{{STRUCTURE_3ttz| PDB=3ttz | SCENE= }} | |||
===Crystal structure of a topoisomerase ATPase inhibitor=== | |||
<!-- | |||
The line below this paragraph, {{ABSTRACT_PUBMED_22041057}}, adds the Publication Abstract to the page | |||
(as it appears on PubMed at http://www.pubmed.gov), where 22041057 is the PubMed ID number. | |||
--> | |||
{{ABSTRACT_PUBMED_22041057}} | |||
==About this Structure== | |||
[[3ttz]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Staphylococcus_aureus Staphylococcus aureus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3TTZ OCA]. | |||
==Reference== | |||
<ref group="xtra">PMID:022041057</ref><references group="xtra"/> | |||
[[Category: Staphylococcus aureus]] | |||
[[Category: Boriack-Sjodin, P A.]] | |||
[[Category: Eakin, A E.]] | |||
[[Category: Read, J.]] | |||
[[Category: Sherer, B A.]] | |||
[[Category: Antimicrobial]] | |||
[[Category: Atp-binding]] | |||
[[Category: Isomerase-isomerase inhibitor complex]] | |||
[[Category: Protein-inhibitor complex]] | |||
[[Category: Structure-based drug design]] | |||
Revision as of 12:15, 16 November 2011
Crystal structure of a topoisomerase ATPase inhibitor
Template:ABSTRACT PUBMED 22041057
About this Structure
3ttz is a 2 chain structure with sequence from Staphylococcus aureus. Full crystallographic information is available from OCA.
Reference
- Sherer BA, Hull K, Green O, Basarab G, Hauck S, Hill P, Loch JT 3rd, Mullen G, Bist S, Bryant J, Boriack-Sjodin A, Read J, Degrace N, Uria-Nickelsen M, Illingworth RN, Eakin AE. Pyrrolamide DNA gyrase inhibitors: Optimization of antibacterial activity and efficacy. Bioorg Med Chem Lett. 2011 Oct 12. PMID:22041057 doi:10.1016/j.bmcl.2011.10.010
